Related Experiment Video
Updated: Aug 17, 2026

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat
Published on: October 29, 2014
Bacterial meningitis in children
Susana Chávez-Bueno1, George H McCracken
1Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Texas Southwestern Medical Center, Dallas, TX 75390-9063, USA. Susana.Chavez-Bueno@UTSouthwestern.edu
Insights
Bacterial meningitis in children poses diagnostic and treatment challenges, despite advances like vaccines and antibiotics. Further understanding of disease mechanisms is crucial for developing more effective therapies to reduce long-term complications.
Area of Science:
- Pediatrics
- Infectious Diseases
- Neurology
Background:
- Bacterial meningitis is a significant cause of childhood illness and death.
- Before widespread vaccination, nearly 6000 US cases annually, half in children.
- Diagnosis and treatment in children remain challenging, with high morbidity and mortality.
Purpose of the Study:
- To review the challenges in diagnosing and treating bacterial meningitis in children.
- To highlight the role of antibiotics and adjunctive therapies like dexamethasone.
- To emphasize the need for better understanding of pathophysiologic mechanisms for future therapies.
Main Methods:
- Review of existing literature on bacterial meningitis in children.
- Analysis of historical data regarding incidence and outcomes.
- Discussion of current treatment strategies and their effectiveness.
Main Results:
- Bacterial meningitis continues to present diagnostic and therapeutic difficulties in pediatric populations.
- Antibiotics and dexamethasone are key in preventing neurologic sequelae.
- High morbidity and case-fatality rates persist globally.
Conclusions:
- Prompt diagnosis and effective treatment are critical for improving outcomes in pediatric bacterial meningitis.
- Further research into the pathophysiology of meningitis is essential for developing improved therapeutic interventions.
- Enhanced understanding may lead to more effective treatments and reduced long-term complications.
Abstract:
Microbiologic causes of meningitis include bacteria, viruses, fungi, and parasites. Before routine use of pneumococcal conjugate vaccine, bacterial meningitis affected almost 6000 people every year in the United States, and about half of all cases occurred in children 18 years old or younger. Prompt and accurate diagnosis and adequate treatment of bacterial meningitis in children remains a major challenge, as reflected by the continued high morbidity and case-fatality rates of the disease worldwide. Appropriate use of antibiotics, along with adjunctive therapies, such dexamethasone, has proved helpful in the prevention of neurologic sequelae in children with bacterial meningitis. Better understanding of pathophysiologic mechanisms likely would result in more effective therapies in the future.
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial Meningitis
Bacterial Meningitis II: Pathophysiology
Viral Meningitis
Cryptococcal Meningitis
Encephalitis l: Introduction

